Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicityM A Caligiuri, C Murray, R J Soiffer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Recovery after stem-cell transplantation for hematologic diseasesS J Lee, D Fairclough, S K Parsons, et al.
Blood|October 1, 1993
Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantationR J Soiffer, R Gonin, C Murray, et al.
Blood|June 20, 1998
Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplantE P Alyea, R J Soiffer, C Canning, et al.
The Journal of Clinical Investigation|September 7, 2000
Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemiaC J Wu, X F Yang, S McLaughlin, et al.
Bone Marrow Transplantation|February 16, 2010
Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapyP Armand, H T Kim, E Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrowR J Soiffer, C Murray, P Mauch, et al.
The Journal of Clinical Investigation|January 1, 1993
Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2M A Caligiuri, C Murray, M J Robertson, et al.
Blood|August 15, 1993
Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemiaS N Rabinowe, R J Soiffer, J G Gribben, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1993
Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot studyA S Freedman, T Takvorian, D Neuberg, et al.
Pageof 8